MARKET STRUCTURE · COMPETITIVE · INDIA
Indigenous Td vaccine added to India’s Universal Immunization Programme
The Hindu
21 Feb · 6:04 PM
Change
India formally launched an indigenously manufactured tetanus and adult diphtheria (Td) vaccine at CRI Kasauli and introduced it for supply under the Universal Immunization Programme (UIP).
Why it matters
The Td vaccine’s inclusion under UIP converts the launch into an operational supply commitment rather than a standalone product announcement. CRI Kasauli is slated to deliver 5.5 million doses through UIP by April 2026, creating a defined near-term volume and timing constraint for immunisation logistics. The shift to an indigenous supplier changes procurement dependence and may alter tendering, pricing, and allocation dynamics for Td doses within public channels. Planned progressive scale-up in subsequent years implies expanding capacity will be tied to CRI’s production ramp and quality-release cadence. The change affects how adult Td coverage is supplied through government immunisation infrastructure starting in the current cycle.
Implications
- • UIP Td dose sourcing shifts to CRI domestic supply
- • 5.5M-dose delivery window set through April 2026
- • Public immunisation logistics must absorb new Td volumes
- • Future UIP Td availability tied to CRI scale-up pace
Who is affected
- • Universal Immunization Programme (UIP) procurement and supply-chain teams
- • Central Research Institute (CRI) vaccine manufacturing and QA units
- • State immunisation departments and cold-chain operators
- • Public-sector vaccine distributors and tender participants
Source
Read full article on The Hindu →
Topics
Business & Markets Supply Chain & Logistics Health & Medicine Public Health Healthcare Systems